Federal contract award
75F40124C00053
TO PROVIDE THE CDRH?S OFFICE OF THE CENTER DIRECTOR (OCD) AND THE CVM WITH THE PROFESSIONAL SUPPORT SERVICES OF A SME IX TO PROVIDE SUPPORT RELATED TO THE MDUFA, ADUFA, AND AGDUFA. THE SME IX SHALL SUPPORT THE EXISTING USER FEE ACTS AND ASSIST FDA LE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541611 — Administrative Management and General Management Consulting Services |
| PSC | R499 — Other Professional Services |
| Parent award / vehicle | Not reported |
| Set-aside | 8(A) SOLE SOURCE |
| Pricing type | LABOR HOURS |
| Obligations | $1.9M |
| Current contract value | $1.9M |
| Potential contract value / ceiling | $1.9M |
| Start date | May 6, 2024 |
| Current end date | May 12, 2027 |
| Potential end date | May 12, 2027 |
| Latest award activity | Mar 25, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 25, 2026 | P00002 | $667.8K | TO PROVIDE THE CDRH'S OFFICE OF THE CENTER DIRECTOR (OCD) AND THE CVM WITH THE PROFESSIONAL SUPPORT SERVICES OF A SME IX TO PROVIDE SUPPORT RELATED TO THE MDUFA, ADUFA, AND AGDUFA. THE SME IX SHALL SUPPORT THE EXISTING USER FEE ACTS AND ASSIST F |
| May 14, 2025 | P00001 | $648.3K | TO PROVIDE THE CDRH?S OFFICE OF THE CENTER DIRECTOR (OCD) AND THE CVM WITH THE PROFESSIONAL SUPPORT SERVICES OF A SME IX TO PROVIDE SUPPORT RELATED TO THE MDUFA, ADUFA, AND AGDUFA. THE SME IX SHALL SUPPORT THE EXISTING USER FEE ACTS AND ASSIST FDA LE |
| May 6, 2024 | 0 | $629.4K | TO PROVIDE THE CDRH?S OFFICE OF THE CENTER DIRECTOR (OCD) AND THE CVM WITH THE PROFESSIONAL SUPPORT SERVICES OF A SME IX TO PROVIDE SUPPORT RELATED TO THE MDUFA, ADUFA, AND AGDUFA. THE SME IX SHALL SUPPORT THE EXISTING USER FEE ACTS AND ASSIST FDA LE |
Estimated positioning window
Oct 25, 2026 – Jan 23, 2027
65/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 65/100. Available recorded signals: 60 points.
- Contract end 2027-05-12 (199 days from calculation)
- +35 points
- 173 historical awards in this buyer and category group
- +15 points
- 3 recorded award transactions
- +5 points
- Latest award action: 2026-03-25
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.